Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · IEX Real-Time Price · USD
5.05
-0.46 (-8.44%)
At close: Jul 19, 2024, 4:00 PM
4.990
-0.050 (-1.09%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $45.00 million as of July 22, 2024. Its market cap has increased by 29.30% in one year.
Market Cap
45.00M
Enterprise Value
33.67M
1-Year Change
29.30%
Ranking
Category
Stock Price
$5.05
Market Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $45.00M, a decrease of -1.75%. That is a compound annual growth rate of -0.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 45.00M | -7.98% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 46.42M |
| Protara Therapeutics | 45.92M |
| Kezar Life Sciences | 45.87M |
| Daxor | 45.85M |
| Carisma Therapeutics | 45.70M |
| Matinas BioPharma Holdings | 44.97M |
| Lucid Diagnostics | 44.71M |
| Regencell Bioscience Holdings | 44.50M |